VERTEX PHARMACEUTICALS INC / MA ($VRTX)
McKechnie Duncan โ EVP, Chief Commercial Officer
Shares
2,500
Price
$486.35
Total Value
$1,215,875.00
Nearby Earnings
Feb 12, 2026
EPS:5.03 (est: 5.11)-1.6%
Revenue:$3.23B (est: $3.18B)+1.4%
Transaction Details
| Insider | McKechnie Duncan |
|---|---|
| Title | EVP, Chief Commercial Officer |
| Transaction Date | Feb 25, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 26, 2026 |
| Shares Sold | 2,500 |
| Price per Share | $486.35 |
| Total Value | $1,215,875.00 |
| Shares Owned After | 19,969 |
| Derivative | No |
| Accession Number | 0000875320-26-000116 |
| Document | View SEC Filing |